These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10811300)

  • 1. Transmucosal delivery systems for calcitonin: a review.
    Torres-Lugo M; Peppas NA
    Biomaterials; 2000 Jun; 21(12):1191-6. PubMed ID: 10811300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein and peptide parenteral controlled delivery.
    Pawar R; Ben-Ari A; Domb AJ
    Expert Opin Biol Ther; 2004 Aug; 4(8):1203-12. PubMed ID: 15268656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salmon calcitonin-loaded Eudragit® and Eudragit®-PLGA nanoparticles: in vitro and in vivo evaluation.
    Cetin M; Aktas MS; Vural I; Ozturk M
    J Microencapsul; 2012; 29(2):156-66. PubMed ID: 22126314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-responsive and enzymatically-responsive hydrogel microparticles for the oral delivery of therapeutic proteins: Effects of protein size, crosslinking density, and hydrogel degradation on protein delivery.
    Koetting MC; Guido JF; Gupta M; Zhang A; Peppas NA
    J Control Release; 2016 Jan; 221():18-25. PubMed ID: 26616761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable poly(DL-lactic acid) formulations in a calcitonin delivery system.
    Asano M; Yoshida M; Omichi H; Mashimo T; Okabe K; Yuasa H; Yamanaka H; Morimoto S; Sakakibara H
    Biomaterials; 1993 Aug; 14(10):797-9. PubMed ID: 8218732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
    Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
    J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proprietary Rel-Ease drug delivery technology: opportunity for sustained delivery of peptides, proteins and small molecules.
    Ye M; Bhat G; Johnston KA; Tan H; Garnick M
    Expert Opin Drug Deliv; 2006 Sep; 3(5):663-75. PubMed ID: 16948561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complexation hydrogels for intestinal delivery of interferon beta and calcitonin.
    Kamei N; Morishita M; Chiba H; Kavimandan NJ; Peppas NA; Takayama K
    J Control Release; 2009 Mar; 134(2):98-102. PubMed ID: 19095021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and evaluation of poly(DL-lactic-co-glycolic acid) nanocomposite particles containing salmon calcitonin for inhalation.
    Yang M; Yamamoto H; Kurashima H; Takeuchi H; Yokoyama T; Tsujimoto H; Kawashima Y
    Eur J Pharm Sci; 2012 Aug; 46(5):374-80. PubMed ID: 22414702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro-In Vivo Evaluation of an Oral Ghost Drug Delivery Device for the Delivery of Salmon Calcitonin.
    Hibbins AR; Govender M; Indermun S; Kumar P; du Toit LC; Choonara YE; Pillay V
    J Pharm Sci; 2018 Jun; 107(6):1605-1614. PubMed ID: 29452142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymeric delivery of proteins and plasmid DNA for tissue engineering and gene therapy.
    Richardson TP; Murphy WL; Mooney DJ
    Crit Rev Eukaryot Gene Expr; 2001; 11(1-3):47-58. PubMed ID: 11693965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Absorption of calcitonin in oral and pulmonary administration with polymer-coated liposomes].
    Takeuchi H; Sugihara H
    Yakugaku Zasshi; 2010 Sep; 130(9):1135-42. PubMed ID: 20823671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transmucosal delivery system of calcitonin].
    Takama S; Hibi T; Konishi R
    Nihon Rinsho; 1989 Jun; 47(6):1335-9. PubMed ID: 2769993
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative assessment of in vitro release kinetics of calcitonin polypeptide from biodegradable microspheres.
    Prabhu S; Sullivan JL; Betageri GV
    Drug Deliv; 2002; 9(3):195-8. PubMed ID: 12396737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current status and perspective of research on PEG-PLGA].
    Zhou HN; Li YM; Liu T
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):561-3. PubMed ID: 21122404
    [No Abstract]   [Full Text] [Related]  

  • 16. Biodegradable nanoparticles for cytosolic delivery of therapeutics.
    Vasir JK; Labhasetwar V
    Adv Drug Deliv Rev; 2007 Aug; 59(8):718-28. PubMed ID: 17683826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats.
    Lowe PJ; Temple CS
    J Pharm Pharmacol; 1994 Jul; 46(7):547-52. PubMed ID: 7996380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis.
    Bandeira L; Lewiecki EM; Bilezikian JP
    Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):681-9. PubMed ID: 27070719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral salmon calcitonin--pharmacology in osteoporosis.
    Henriksen K; Bay-Jensen AC; Christiansen C; Karsdal MA
    Expert Opin Biol Ther; 2010 Nov; 10(11):1617-29. PubMed ID: 20932224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and in vitro-in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles.
    Glowka E; Sapin-Minet A; Leroy P; Lulek J; Maincent P
    J Microencapsul; 2010; 27(1):25-36. PubMed ID: 19229671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.